Initial experience of intravesical gemcitabine for patients with high-risk superficial transitional cell carcinoma of the bladder following BCG failure. [electronic resource]
Producer: 20140708Description: 95-9 p. digitalISSN:- 1053-816X
- Administration, Intravesical
- Aged
- Aged, 80 and over
- Antimetabolites, Antineoplastic -- administration & dosage
- BCG Vaccine -- therapeutic use
- Carcinoma, Transitional Cell -- drug therapy
- Deoxycytidine -- administration & dosage
- Female
- Humans
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- prevention & control
- Risk Factors
- Treatment Failure
- Urinary Bladder Neoplasms -- drug therapy
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.